CD4 and neoplasm: Similar results were found in colorectal cancer and in melanoma, where HLA-DR expression was associated with therapeutic response to immunotherapy, better progression free survival, overall survival (OS) and CD4+ and CD8+ T cells tumor infiltrate [28, 41].